CH714997B1 - Solid preparation for the preparation of a functional beverage and process for its preparation. - Google Patents
Solid preparation for the preparation of a functional beverage and process for its preparation. Download PDFInfo
- Publication number
- CH714997B1 CH714997B1 CH10052018A CH10052018A CH714997B1 CH 714997 B1 CH714997 B1 CH 714997B1 CH 10052018 A CH10052018 A CH 10052018A CH 10052018 A CH10052018 A CH 10052018A CH 714997 B1 CH714997 B1 CH 714997B1
- Authority
- CH
- Switzerland
- Prior art keywords
- amounts
- quantities
- extracted
- extract
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title abstract description 6
- 235000020510 functional beverage Nutrition 0.000 title abstract description 3
- 230000008569 process Effects 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 55
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 50
- 108010035532 Collagen Proteins 0.000 claims abstract description 40
- 102000008186 Collagen Human genes 0.000 claims abstract description 40
- 229920001436 collagen Polymers 0.000 claims abstract description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 38
- 240000008042 Zea mays Species 0.000 claims abstract description 36
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 36
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 31
- 235000005822 corn Nutrition 0.000 claims abstract description 31
- 235000018102 proteins Nutrition 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 22
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 20
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 20
- 241000251511 Holothuroidea Species 0.000 claims abstract description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 20
- 108010074686 Selenoproteins Proteins 0.000 claims abstract description 20
- 102000008114 Selenoproteins Human genes 0.000 claims abstract description 20
- 241001046595 Mora moro Species 0.000 claims abstract description 19
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 19
- 229960001231 choline Drugs 0.000 claims abstract description 19
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960003495 thiamine Drugs 0.000 claims abstract description 19
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 19
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 19
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 19
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 19
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 18
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 18
- 239000011718 vitamin C Substances 0.000 claims abstract description 18
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 17
- 239000005018 casein Substances 0.000 claims abstract description 17
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000021240 caseins Nutrition 0.000 claims abstract description 17
- 235000012680 lutein Nutrition 0.000 claims abstract description 17
- 229960005375 lutein Drugs 0.000 claims abstract description 17
- 239000001656 lutein Substances 0.000 claims abstract description 17
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 17
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 17
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 17
- 235000003368 Ilex paraguariensis Nutrition 0.000 claims abstract description 15
- 244000302512 Momordica charantia Species 0.000 claims abstract description 15
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 15
- 235000020331 mate tea Nutrition 0.000 claims abstract description 15
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000191896 Rana sylvatica Species 0.000 claims abstract description 14
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 14
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 14
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 14
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 14
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 5
- 235000009973 maize Nutrition 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 abstract description 15
- 244000068988 Glycine max Species 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 10
- 239000005515 coenzyme Substances 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 5
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 2
- 108010053481 Antifreeze Proteins Proteins 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005102 Kashin-Beck Disease Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000004221 bone function Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000036624 brainpower Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002872 effect on rheumatism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002468 redox effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008348 synthetic phosphatidyl choline Substances 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Die vorliegende Erfindung betrifft ein festes Präparat für die Zubereitung eines Getränks, insbesondere eines funktionellen Getränks, umfassend die folgenden Gewichtskomponenten: 14 bis 16 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 14 bis 16 Mengen Sojapeptid; 14 bis 16 Mengen Kollagen-Tripeptid; 14 bis 16 Mengen Bittermelone-Extrakt; 14 bis 16 Mengen Yak-Knochenmark-Extrakt; 9 bis 12 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.2 bis 0.8 Mengen Seegurkenextrakt; 0.2 bis 0.8 Mengen Coenzym Q10; 0.2 bis 0.3 Mengen Selenoprotein; 0.05 bis 0.1 Mengen Lutein; 0.2 bis 0.3 Mengen Caseinphosphopeptid; 0.03 bis 0.1 Mengen Vitamin B1; 0.03 bis 0.1 Mengen Cholin; 0.05 bis 0.15 Mengen Vitamin C; 4 bis 6 Mengen Gynostemma-pentaphyllum-Extrakt; 4 bis 6 Mengen von einem aus Mais extrahierten Peptid; 0.05 bis 2 Mengen von einem aus Mais extrahierten Protein; 0.05 bis 2 Mengen Mate-Tee-Pulver; 0.02 bis 0.06 Mengen Hefe, und die Erfindung veröffentlicht auch ein entsprechendes Herstellungsverfahren.The present invention relates to a solid preparation for the preparation of a beverage, in particular a functional beverage, comprising the following components by weight: 14 to 16 quantities of collagen extracted from the skin of deep-sea cod; 14 to 16 amounts of soybean peptide; 14 to 16 levels of collagen tripeptide; 14 to 16 amounts of bitter melon extract; 14 to 16 amounts of yak bone marrow extract; 9 to 12 quantities of oil extracted from Rana sylvatica; 0.2 to 0.8 quantities of sea-cucumber extract; 0.2 to 0.8 amounts of coenzyme Q10; 0.2 to 0.3 amounts of selenoprotein; 0.05 to 0.1 levels of lutein; 0.2 to 0.3 amounts of casein phosphopeptide; 0.03 to 0.1 amounts of vitamin B1; 0.03 to 0.1 amounts of choline; 0.05 to 0.15 levels of vitamin C; 4 to 6 amounts of Gynostemma pentaphyllum extract; 4 to 6 amounts of a peptide extracted from maize; 0.05 to 2 levels of protein extracted from corn; 0.05 to 2 quantities of mate tea powder; 0.02 to 0.06 levels of yeast, and the invention also discloses a corresponding method of preparation.
Description
Beschreibung Gebiet der Erfindung [0001] Die vorliegende Erfindung betrifft ein festes Präparat für die Zubereitung eines funktionellen Getränks und ein Verfahren zu seiner Herstellung.Description Field of the Invention The present invention relates to a solid preparation for the preparation of a functional drink and a method for its preparation.
Hintergrund der Erfindung [0002] Funktionale Getränke sind Getränke, deren Zusammensetzung und Gehaltsverhältnis natürlicher Nährstoffe der Ernährungsbedürfnisse bestimmter spezieller Populationen angepasst sind. Sie regulieren die Körperfunktionen, aber bezwecken nicht die Behandlung von Krankheiten. Derzeit sind funktionale Getränke bei den Verbrauchern in der Schweiz zunehmend beliebt, und die Schweiz ist nach und nach zu einer Hauptkonsumentin von funktionellen Getränken geworden.Background of the Invention Functional beverages are beverages, the composition and content ratio of natural nutrients of which are adapted to the nutritional needs of certain special populations. They regulate body functions, but are not intended to treat diseases. Functional drinks are currently becoming increasingly popular among consumers in Switzerland, and Switzerland has gradually become a major consumer of functional drinks.
[0003] Gegenwärtig sind die meisten der gebräuchlichsten funktionellen Getränke flüssige funktionelle Getränke, die direkt konsumiert werden können. Die flüssigen funktionellen Getränke sind schön verpackt und bequem zu trinken, aber der Raum und das Gewicht, in dem die Flüssigkeit eingenommen wird, sind relativ gross, und wenn die fertigen flüssigen funktionellen Getränke für eine lange Zeit gelagert werden, nehmen sie eine bestimmte Temperatur an, die zur Zeit des Verzehrs nicht sofort zur gewünschten Temperatur geändert werden kann. Im Gegensatz dazu sind feste Präparate für die Zubereitung von funktionellen Getränken leicht zu tragen und können mit Wasser mit der gewünschten Temperatur verwendet werden, was grosse Entwicklungsperspektiven hat.Currently, most of the most common functional drinks are liquid functional drinks that can be consumed directly. The liquid functional drinks are nicely packaged and convenient to drink, but the space and weight in which the liquid is taken are relatively large, and when the finished liquid functional drinks are stored for a long time, they reach a certain temperature that cannot be changed to the desired temperature immediately at the time of consumption. In contrast, solid preparations for the preparation of functional drinks are easy to carry and can be used with water at the desired temperature, which has great development prospects.
[0004] Kollagen ist ein makromolekulares funktionelles Protein, eine Hauptkomponente der Haut, die eine Vielzahl von Aminosäuren enthält. Fischkollagenpeptid ist ein reparierendes Kollagen, das die wichtigste Komponente der biologischen Polymeren der extrazellulären Matrix ist. Fischkollagen enthält viele Aminosäuren wie Glycin, Prolin und Hydroxyprolin, die vom menschlichen Körper benötigt werden. Tiefsee-Kabeljau ist nicht anfällig für Tierkrankheiten und enthält ein einzigartiges Frostschutzprotein, das gegenwärtig eine gut bekannte Quelle für Fischkollagen ist. Das aus Tiefsee-Kabeljau extrahierte Peptid wird in funktionellen Getränken verwendet, ergänzt durch andere funktionelle Nährstoffe, die die Funktion funktioneller Getränke stark verbessern können.[0004] Collagen is a macromolecular functional protein, a major component of the skin that contains a variety of amino acids. Fish collagen peptide is a repairing collagen that is the most important component of the biological polymers of the extracellular matrix. Fish collagen contains many amino acids such as glycine, proline and hydroxyproline, which are needed by the human body. Deep-sea cod is not susceptible to animal diseases and contains a unique antifreeze protein that is currently a well-known source of fish collagen. The peptide extracted from deep-sea cod is used in functional drinks, supplemented by other functional nutrients that can greatly improve the function of functional drinks.
Zusammenfassung der Erfindung [0005] Der vorliegenden Erfindung liegt die Aufgabe zugrunde, ein festes Präparat für die Zubereitung eines funktionellen Getränks bereitzustellen, das eine vernünftige Formulierung und Vorteile für den menschlichen Körper aufweist.SUMMARY OF THE INVENTION It is the object of the present invention to provide a solid preparation for the preparation of a functional drink which has a reasonable formulation and advantages for the human body.
[0006] Um die obige Aufgabe zu lösen, ist die technische Lösung der vorliegenden Erfindung:To achieve the above object, the technical solution of the present invention is:
[0007] Ein festes Präparat für die Zubereitung eines funktionellen Getränks, umfassend die folgenden Gewichtskomponenten: 14 bis 16 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 14 bis 16 Mengen Sojapeptid; 14 bis 16 Mengen Kollagen-Tripeptid; 14 bis 16 Mengen Bittermelone-Extrakt; 14 bis 16 Mengen Yak-Knochenmark-Extrakt; 9 bis 12 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.2 bis 0.8 Mengen Seegurkenextrakt; 0.2 bis 0.8 Mengen Coenzym O10; 0.2 bis 0.3 Mengen Selenoprotein; 0.05 bis 0.1 Mengen Lutein; 0.2 bis 0.3 Mengen Caseinphosphopeptid; 0.03 bis 0.1 Mengen Vitamin B1; 0.03 bis 0.1 Mengen Cholin; 0.05 bis 0.15 Mengen Vitamin C; 4 bis 6 Mengen Gynostemma-pentaphyllum-Extrakt; 4 bis 6 Mengen von einem aus Mais extrahierten Peptid; 0.05 bis 2 Mengen von einem aus Mais extrahierten Protein; 0.05 bis 2 Mengen Mate-Tee-Pulver; 0.02 bis 0.06 Mengen Hefe.A solid preparation for the preparation of a functional drink, comprising the following weight components: 14 to 16 amounts of collagen extracted from the skin of deep-sea cod; 14 to 16 amounts of soy peptide; 14 to 16 amounts of collagen tripeptide; 14 to 16 quantities of bitter melon extract; 14 to 16 amounts of yak bone marrow extract; 9 to 12 amounts of oil extracted from Rana Sylvatica; 0.2 to 0.8 quantities of sea cucumber extract; 0.2 to 0.8 amounts of coenzyme O10; 0.2 to 0.3 amounts of selenoprotein; 0.05 to 0.1 amounts of lutein; 0.2 to 0.3 amounts of casein phosphopeptide; 0.03 to 0.1 amounts of vitamin B1; 0.03 to 0.1 amounts of choline; 0.05 to 0.15 amounts of vitamin C; 4 to 6 amounts of Gynostemma pentaphyllum extract; 4 to 6 amounts of a peptide extracted from corn; 0.05 to 2 amounts of a protein extracted from corn; 0.05 to 2 quantities of mate tea powder; 0.02 to 0.06 quantities of yeast.
[0008] Vorzugsweise weist das feste Präparat für die Zubereitung eines funktionellen Getränks die folgenden Gewichtskomponenten auf: 15 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 15 Mengen Sojapeptid; 15 Mengen Kollagen-Tripeptid; 15 Mengen Bittermelone-Extrakt; 15 Mengen Yak-Knochenmark-Extrakt; 10 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.5 Mengen Seegurkenextrakt; 0.5 Mengen Coenzym 010; 0.25 Mengen Selenoprotein; 0.05 Mengen Lutein; 0.25 Mengen Caseinphosphopeptid; 0.05 Mengen Vitamin B1; 0.05 Mengen Cholin; 0.1 Mengen Vitamin C; 5 Mengen Gynostemma-pentaphyllum-Extrakt; 5 Mengen von einem aus Mais extrahierten Peptid; 1 Menge von einem aus Mais extrahierten Protein; 1 Menge Mate-Tee-Pulver; 0.05 Mengen Hefe.Preferably, the solid preparation for the preparation of a functional drink has the following weight components: 15 amounts of collagen extracted from the skin of deep-sea cod; 15 quantities of soy peptide; 15 amounts of collagen tripeptide; 15 quantities of bitter melon extract; 15 quantities of yak bone marrow extract; 10 quantities of oil extracted from Rana Sylvatica; 0.5 quantities of sea cucumber extract; 0.5 quantities of coenzyme 010; 0.25 quantities of selenoprotein; 0.05 amounts of lutein; 0.25 quantities of casein phosphopeptide; 0.05 amounts of vitamin B1; 0.05 amounts of choline; 0.1 amounts of vitamin C; 5 quantities of Gynostemma pentaphyllum extract; 5 amounts of a peptide extracted from corn; 1 amount of a protein extracted from corn; 1 amount of mate tea powder; 0.05 quantities of yeast.
[0009] Ein Herstellungsverfahren für das feste Präparat für die Zubereitung eines funktionellen Getränks umfasst die folgenden Schritte:A manufacturing process for the solid preparation for the preparation of a functional drink comprises the following steps:
[0010] (1) Die Rohmaterialien werden gemäss dem obigen Gewichtsverhältnis gewogen;(1) The raw materials are weighed according to the above weight ratio;
[0011] (2) aus der Haut von Tiefsee-Kabeljau extrahiertes Kollagen, Sojapeptid, Bittermelone-Extrakt, Yak-KnochenmarkExtrakt, aus Rana Sylvatica extrahiertes Öl, Seegurkenextrakt, Gynostemma-pentaphyllum-Extrakt, ein aus Mais extrahiertes Peptid und Mate-Tee-Pulver werden zusammengemischt und einheitlich gerührt, um ein Rohmaterialpulver zu bilden;(2) Collagen extracted from the skin of deep-sea cod, soy peptide, bitter melon extract, yak bone marrow extract, oil extracted from Rana Sylvatica, sea cucumber extract, gynostemma pentaphyllum extract, a peptide extracted from maize and mate tea Powders are mixed together and stirred uniformly to form a raw material powder;
[0012] (3) Coenzym O10, Selenoprotein, Lutein, Caseinphosphopeptid, Vitamin B1, Cholin, Vitamin C, ein aus Mais extrahiertes Protein und Hefe werden dem Rohmaterialpulver zugebracht, gleichmässig gemischt und dann getrocknet.(3) Coenzyme O10, selenoprotein, lutein, casein phosphopeptide, vitamin B1, choline, vitamin C, a protein extracted from corn and yeast are added to the raw material powder, mixed uniformly and then dried.
Ausführliche Beschreibung einiger Ausführungsformen [0013] Um den Inhalt der vorliegenden Erfindung besser zu verstehen, werden die technischen Lösungen in den Ausführungsformen der vorliegenden Erfindung nachfolgend klar und vollständig beschrieben.Detailed Description of Some Embodiments To better understand the content of the present invention, the technical solutions in the embodiments of the present invention are clearly and fully described below.
CH 714 997 B1 [0014] Tiefsee-Kabeljau-Peptid: Gegenwärtig ist das Tiefsee-Kabeljau-Kollagen hauptsächlich aus der Haut von TiefseeKabeljau extrahiert, weil Tiefsee-Kabeljau nicht anfällig für Tierkrankheiten ist und ein einzigartiges Frostschutzprotein enthält, das gegenwärtig eine gut bekannte Quelle für Fischkollagen ist. Das niedermolekulare Peptid aus Fischkollagen enthält 18 Arten von Aminosäuren, äusser Tryptophan und Cystein, und darunter 7 Arten von Aminosäuren, die für die Aufrechterhaltung des menschlichen Wachstums notwendig sind. Das Kollagen enthält 30% Glycin, etwa 25% Prolin und Hydroxyprolin, das ist der höchste Gehalt an verschiedenen Proteinen. Der Gehalt an Alanin und Glutaminsäure ist auch relativ hoch und das Kollagen enthält auch Hydroxyprolin, Pyroglutaminsäure und Hydroxylysin, die in anderen üblichen Proteinen selten sind, und ist also sehr reich an Nährstoffen.CH 714 997 B1 Deep Sea Cod Peptide: At present, the deep sea cod collagen is mainly extracted from the skin of deep sea cod because deep sea cod is not susceptible to animal diseases and contains a unique antifreeze protein which is currently a well known source for fish collagen. The low molecular weight peptide from fish collagen contains 18 types of amino acids, except tryptophan and cysteine, including 7 types of amino acids that are necessary for the maintenance of human growth. The collagen contains 30% glycine, about 25% proline and hydroxyproline, which is the highest content of various proteins. The alanine and glutamic acid content is also relatively high and the collagen also contains hydroxyproline, pyroglutamic acid and hydroxylysine, which are rare in other common proteins, and is therefore very rich in nutrients.
[0015] Sojapeptid: Sojapeptid ist ein kleines Molekülfragment eines grösseren Moleküls, Sojaprotein, und ist aus 2 bis 10 Aminosäuren zusammengesetzt. Soja-Peptid enthält 22 verschiedene Aminosäuren, darunter 9 essentielle Aminosäuren, die der menschliche Körper nicht synthetisieren kann. Sojabohnenpeptid ist ein niedermolekulares Protein, das leicht vom menschlichen Körper absorbiert wird und für Personen mit schlechter Proteinverdauung und -absorption geeignet ist, wie Patienten mittleren Alters und ältere Menschen, Patienten, die sich von Operationen erholen, Patienten mit Tumoren, die sich einer Strahlentherapie und Chemotherapie unterziehen, oder Menschen mit schlechter Magen-Darm-Funktion. Darüber hinaus hat Sojapeptid auch die Wirkung, das Immunsystem zu verbessern, die körperliche Stärke zu verbessern, Müdigkeit zu lindern und den Blutdruck, das Blutfett und den Blutzuckerspiegel zu senken.Soy Peptide: Soy peptide is a small molecular fragment of a larger molecule, soy protein, and is composed of 2 to 10 amino acids. Soybean peptide contains 22 different amino acids, including 9 essential amino acids that the human body cannot synthesize. Soybean peptide is a low molecular weight protein that is easily absorbed by the human body and is suitable for people with poor protein digestion and absorption, such as middle-aged and elderly patients, patients recovering from surgery, patients with tumors undergoing radiation therapy and Undergo chemotherapy, or people with poor gastrointestinal function. In addition, soy peptide also has the effect of improving the immune system, improving physical strength, relieving fatigue and lowering blood pressure, blood fat and blood sugar levels.
[0016] Kollagen-Tripeptid: Die kleinste Struktureinheit von Kollagen, die aus Schweinehaut und Fischhaut mit fortschrittlichen biotechnischen Verfahren hergestellt wird. Es ist ein Tripeptid, das Glycin, Prolin (oder Hydroxyprolin) plus eine andere Aminosäure enthält. Es werden fortgeschrittene biotechnische Techniken verwendet, um kleine molekulare Strukturen abzufangen, die in grossen Kollagenmolekülen der Haut nützlich sind. Da das Molekulargewicht des Kollagen-Tripeptids gering ist, kann es vom menschlichen Körper ausreichend absorbiert werden, und gleichzeitig kann das Kollagen-Tripeptid äusserst effizient in das Stratum corneum, die Dermisschicht und die Haarwurzelzellen infiltriert werden.Collagen tripeptide: The smallest structural unit of collagen, which is made from pig skin and fish skin using advanced biotechnological processes. It is a tripeptide that contains glycine, proline (or hydroxyproline) plus another amino acid. Advanced biotechnology techniques are used to trap small molecular structures that are useful in large skin collagen molecules. Since the molecular weight of the collagen tripeptide is low, it can be absorbed sufficiently by the human body, and at the same time the collagen tripeptide can be infiltrated extremely efficiently into the stratum corneum, the dermis layer and the hair root cells.
[0017] Bittermelone-Peptid: ist eine biologisch aktive Substanz, die aus Bittermelone extrahiert wird. Es besteht aus 17 Arten von 166 Aminosäuren. Es hat eine ähnliche Struktur und physikalische und chemische Indikatoren zu Insulin und hat eine signifikante Blutzucker-regulierende Wirkung. Es ist ein natürliches Gesundheitspflegeprodukt.Bitter melon peptide: is a biologically active substance extracted from bitter melon. It consists of 17 types of 166 amino acids. It has a similar structure and physical and chemical indicators to insulin and has a significant blood sugar regulating effect. It is a natural health care product.
[0018] Yak-Knochen-Peptid: Das Yak-Knochenmark wird aus dem tierischen Yak-Knochen gewonnen und sein Geschmack und seine Natur sind sehr ruhig. Es hat eine gesundheitsfördernde Wirkung auf Leber und Niere und kann auch die Knochen stärken. Yak-Knochenextrakt hat eine gute gesundheitliche Wirkung auf Rheuma, Muskel- und Knochenschmerzen und schwache Taille und Knie. Der Yak-Knochen enthält Kalzium, Kupfer, Zink und andere Elemente und Knochenkollagenpeptid, Polysaccharide usw., die die Entwicklung von Knochenentwicklung und Knochenverletzung höher fördern als der durchschnittliche Pflanzenfresser-Knochen.Yak bone peptide: The yak bone marrow is obtained from animal yak bone and its taste and nature are very calm. It has a health-promoting effect on the liver and kidneys and can also strengthen the bones. Yak bone extract has a good health effect on rheumatism, muscle and bone pain and weak waist and knees. The yak bone contains calcium, copper, zinc and other elements and bone collagen peptide, polysaccharides, etc., which promote the development of bone development and bone injury more than the average herbivore bone.
[0019] Froschöl: Rana Sylvestris ist eine rare Froschart für Nahrung und Medizin. Es hat einen hohen Nährwert und ist das beste Tonikum für die Verzögerung des Alterns, nährt und stärkt die Immunität. Das aus Rana Sylvatica extrahierte Froschöl gilt seit der Antike als nährendes und stärkendes Mittel. Es kann auch für die Gesundheitspflege verwendet werden, und es hat auch gesundheitliche Auswirkungen auf die Lungen, Nieren und Leber. Froschöl kann Krankheiten wie Neurasthenie, Herzklopfen, Schlaflosigkeit und körperliche Schwäche behandeln und hat eine gute regulierende Funktion am weiblichen Körper.Frog oil: Rana Sylvestris is a rare type of frog for food and medicine. It has a high nutritional value and is the best tonic for delaying aging, nourishes and strengthens immunity. Frog oil extracted from Rana Sylvatica has been a nourishing and strengthening agent since ancient times. It can also be used for health care, and it also has health effects on the lungs, kidneys and liver. Frog oil can treat diseases such as neurasthenia, palpitations, insomnia and physical weakness and has a good regulating function on the female body.
[0020] Seegurkenpeptid: Seegurke hat einen hohen Nährwert und enthält mehr als 50 Arten von Nährstoffen, einschliesslich Polyglucosamin, Mucopolysaccharid, marinem bioaktivem Calcium, hohem Protein, Mucin, Peptid, Kollagen, Nukleinsäure, Seegurkensaponin, Chondroitinsulfat, verschiedenen Vitaminen, verschiedenen Aminosäuren, Säuren und Kohlenhydrate usw. Seegurkenextrakt kann beschädigten Gelenkknorpel effektiv reparieren und die normale Funktion von Knochen und Gelenk wiederherstellen. Gleichzeitig haben die Nährstoffe in Seegurken auch eine Vielzahl von Auswirkungen, einschliesslich: Erweiterung der Blutgefässe, Erhöhung der Durchblutung; Hemmung der Plättchenaggregation, Verbesserung der Fibrinauflösung, Verbesserung der Mikrozirkulation; Förderung der Absorption von entzündlichen Exsudaten; Analgesie, Sedierung, entzündungshemmend, antiinfizierend und verbessern die Immunität des Körpers. Seegurkenpeptid, das aus Seegurken extrahiert wird, kann Zellen nähren, die Knochenmasse erhöhen, die Blutzirkulation fördern, Entzündungen reduzieren und Schmerzen lindern. Methionin, Taurin, Spurenelemente Vanadium, Selen, Tellur und Vitamin PP: Diese Stoffe sind unentbehrliche Substanzen für das menschliche Wachstum und die Entwicklung und spielen eine unersetzbare physiologische Funktion im Körper. Zum Beispiel können Methionin und Taurin das Wachstum fördern und bei Ermüdung entlasten; das Spurenelement Vanadium kann Eisen im Körper effektiver absorbieren und verschiedene Anämien verbessern; elementares Selen und Strontium können freie Radikale beseitigen und haben eine Antikrebswirkung.Sea cucumber peptide: Sea cucumber has a high nutritional value and contains more than 50 types of nutrients, including polyglucosamine, mucopolysaccharide, marine bioactive calcium, high protein, mucin, peptide, collagen, nucleic acid, sea cucumber saponin, chondroitin sulfate, various vitamins, various amino acids, acids and carbohydrates, etc. Sea cucumber extract can effectively repair damaged articular cartilage and restore normal bone and joint function. At the same time, the nutrients in sea cucumbers also have a variety of effects, including: dilating blood vessels, increasing blood flow; Inhibition of platelet aggregation, improvement of fibrin dissolution, improvement of microcirculation; Promoting the absorption of inflammatory exudates; Analgesia, sedation, anti-inflammatory, anti-infectious and improve the immunity of the body. Sea cucumber peptide extracted from sea cucumber can nourish cells, increase bone mass, promote blood circulation, reduce inflammation and relieve pain. Methionine, taurine, trace elements vanadium, selenium, tellurium and vitamin PP: These substances are indispensable substances for human growth and development and play an irreplaceable physiological function in the body. For example, methionine and taurine can promote growth and relieve fatigue; the trace element vanadium can absorb iron in the body more effectively and improve various anemias; Elemental selenium and strontium can eliminate free radicals and have an anti-cancer effect.
[0021] Coenzym Q10: Coenzym Q10 liefert nicht nur Energie für das Herz, sondern hat auch ausgezeichnete Antioxidations- und Radikalfänger-Funktionen. Es kann die Lipidperoxidation in der Blutgefässwand verhindern und Atherosklerose ohne Nebenwirkungen verhindern. Die spezifische Rolle von Coenzym Q10 kann in den folgenden vier Aspekten reflektiert werden: 1) Schutz des Herzens. Coenzym Q10 hilft, den Herzmuskel ausreichend mit Sauerstoff zu versorgen und plötzlichen Herzerkrankungen vorzubeugen. Insbesondere spielt Coenzym Q10 eine Schlüsselrolle bei der Verbesserung der Myokardhypoxie. 2) Schutz der Haut. Die langfristige Anwendung von Coenzym Q10 kann der Hautalterung effektiv vorbeugen und Gesichtsfalten reduzieren. 3) Anti-Müdigkeit. Coenzym Q10 hält die Zellen in einem gesunden Zustand,Coenzyme Q10: Coenzyme Q10 not only provides energy for the heart, but also has excellent antioxidant and radical scavenger functions. It can prevent lipid peroxidation in the blood vessel wall and prevent atherosclerosis without side effects. The specific role of coenzyme Q10 can be reflected in the following four aspects: 1) Protection of the heart. Coenzyme Q10 helps to provide the heart muscle with sufficient oxygen and prevent sudden heart diseases. In particular, coenzyme Q10 plays a key role in improving myocardial hypoxia. 2) Protection of the skin. Long-term use of Coenzyme Q10 can effectively prevent skin aging and reduce facial wrinkles. 3) anti-fatigue. Coenzyme Q10 keeps the cells in a healthy state,
CH 714 997 B1 sodass der Körper voller Energie und Gehirnkraft ist. Die biologische Aktivität von Coenzym Q1O beruht hauptsächlich auf den Redoxeigenschaften seines Anthracenrings und den physikochemischen Eigenschaften seiner Seitenkette. Es ist ein natürlicher Antioxidant und Promotor des Zellmetabolismus, der von den Zellen selbst produziert wird und die Funktion hat, die Integrität der Biofilmstruktur zu schützen und wiederherzustellen und das Membranpotential zu stabilisieren. Es ist ein unspezifischer Immunverstärker des Körpers und zeigt daher ausgezeichnete Anti-Müdigkeits-Effekte. 4) Anti-Krebs. Studien haben gezeigt, dass Coenzym Q1O eine Anti-Tumor-Wirkung hat und eine gewisse heilende Wirkung bei fortgeschrittenem metastasierendem Krebs hat.CH 714 997 B1 so that the body is full of energy and brain power. The biological activity of Coenzyme Q1O is mainly based on the redox properties of its anthracene ring and the physicochemical properties of its side chain. It is a natural antioxidant and promoter of cell metabolism, which is produced by the cells themselves and has the function of protecting and restoring the integrity of the biofilm structure and stabilizing the membrane potential. It is an unspecific immune enhancer of the body and therefore shows excellent anti-fatigue effects. 4) Anti-cancer. Studies have shown that coenzyme Q1O has an anti-tumor effect and has a certain healing effect in advanced metastatic cancer.
[0022] Selenoprotein: Selenoproteine werden hauptsächlich in Selenoprotein, das Selen-Cystein enthält, und Selenoprotein, das Selen-Methionin enthält, klassifiziert. In den meisten Fällen ist Selen-Cystein der wichtigste Medium für Selen. Selen-Cystein wird wegen seiner Bedeutung auch als 21. Aminosäure bezeichnet und ist an der Proteinzusammensetzung von Säugetieren beteiligt. In den meisten Fällen ist Selenoprotein ein Protein, das Selen-Cystein enthält. Zum Beispiel gehört die Thioredoxin-Reduktase des Säugetier-Systems zum Selenoprotein. Selen-Cystein ist eine Kodon-vermittelte, spezifische Kodierungssynthese von UGA über ein mit Selen dotiertes Adjuvans. Selen ist hauptsächlich im Korn durch Selenmethionin oder Selenmethionin vorhanden. Selenmethionin kann das Produkt eines zufälligen Prozesses der Proteinsynthese sein, sodass das Protein, das Selenmethionin enthält, auch Selenoprotein genannt wird.Selenoprotein: Selenoproteins are mainly classified into selenoprotein containing selenium cysteine and selenoprotein containing selenium methionine. In most cases, selenium cysteine is the main medium for selenium. Because of its importance, selenium cysteine is also called the 21st amino acid and is involved in the protein composition of mammals. In most cases, selenoprotein is a protein that contains selenium cysteine. For example, thioredoxin reductase from the mammalian system belongs to selenoprotein. Selenium cysteine is a codon-mediated, specific coding synthesis of UGA using a selenium-doped adjuvant. Selenium is mainly present in the grain through selenium methionine or selenium methionine. Selenium methionine can be the product of a random process in protein synthesis, so the protein that contains selenium methionine is also called selenoprotein.
[0023] Lutein: Lutein ist ein ausgezeichnetes Antioxidans, das Zellen vor Schäden durch freie Radikale schützen kann und dadurch Herz-Kreislauf-Erkrankungen, koronare Herzkrankheiten und Alterserkrankungen vorbeugt. Lutein und Zeaxanthin sind die einzigen zwei Arten von Carotinoiden im Auge. Die einzigartige Funktion von Lutein besteht darin, Sehverlust und Erblindung durch Läsionen im Makulabereich des senilen Auges zu verhindern.Lutein: Lutein is an excellent antioxidant that can protect cells from free radical damage and thereby prevent cardiovascular diseases, coronary heart diseases and old age diseases. Lutein and zeaxanthin are the only two types of carotenoids in the eye. Lutein's unique function is to prevent vision loss and blindness from lesions in the macular area of the senile eye.
[0024] Caseinphosphopeptid: Caseinphosphopeptid ist ein biologisch aktives Polypeptid, das durch Biotechnologie aus bovinem Käseprotein hergestellt wird. Es kann in verschiedenen Nährstoffen und gesunden Lebensmitteln verwendet werden und kann die bivalenten Mineralstoffe des Körpers wie Kalzium, Eisen und Zink wirksam fördern. Die Absorption und Nutzung von bivalenten Mineralstoffen hat auch die Funktion, die Zähne fester und gesunder zu machen und fördert die Reparatur von Karies. Im Vergleich zu Vitamin D hat Caseinphosphopeptid eine hohe Absorptionsrate, keine toxischen Nebenwirkungen und kann die Absorptionsrate anderer zweiwertiger Mineralien wie Zink und Eisen verbessern. Caseinphosphopeptid fördert auch die passive Diffusion von nicht gesättigtem Calcium im unteren Teil des Dünndarms. Die Absorption wird durch Altersveränderungen und Vitamin D nicht beeinflusst.[0024] Casein phosphopeptide: Casein phosphopeptide is a biologically active polypeptide that is produced from bovine cheese protein by biotechnology. It can be used in various nutrients and healthy foods and can effectively promote the body's bivalent minerals such as calcium, iron and zinc. The absorption and use of bivalent minerals also has the function of making the teeth firmer and healthier and promotes the repair of tooth decay. Compared to vitamin D, casein phosphopeptide has a high absorption rate, no toxic side effects and can improve the absorption rate of other divalent minerals like zinc and iron. Casein phosphopeptide also promotes the passive diffusion of unsaturated calcium in the lower part of the small intestine. Absorption is not affected by age changes and vitamin D.
[0025] Vitamin B1: Im menschlichen Körper ist Vitamin B1 in Skelettmuskel-, Herzmuskel-, Leber-, Nieren- und Hirngewebe weit verbreitet, mit einer Halbwertszeit von 9 bis 10 Tagen. In Pflanzen findet sich Vitamin B1 hauptsächlich in der Aussenhaut und den Keimen von Samen in Reiskleie und Kleie, in magerem Fleisch, im Kohl und im Sellerie. Das im Allgemeinen verwendete Vitamin B1 ist ein chemisch synthetisiertes Produkt. Im menschlichen Körper nimmt Vitamin B1 am Katabolismus von Zucker in Form von Coenzym teil, welches die Funktion hat, das Nervensystem zu schützen; es kann auch die gastrointestinale Motilität fördern und den Appetit steigern. Ein Mangel an Vitamin B1 kann eine Vielzahl von neurologischen Entzündungen wie Beriberi und Polyneuritis verursachen.Vitamin B1: In the human body, vitamin B1 is widespread in skeletal muscle, heart muscle, liver, kidney and brain tissue, with a half-life of 9 to 10 days. In plants, vitamin B1 is mainly found in the outer skin and the germs of seeds in rice bran and bran, in lean meat, in cabbage and in celery. The commonly used vitamin B1 is a chemically synthesized product. In the human body, vitamin B1 participates in the catabolism of sugar in the form of coenzyme, which has the function of protecting the nervous system; it can also promote gastrointestinal motility and increase appetite. A lack of vitamin B1 can cause a variety of neurological inflammations such as beriberi and polyneuritis.
[0026] Vitamin C: Vitamin C, auch bekannt als Ascorbinsäure, ist ein farbloser und geruchloser flockiger Kristall. Vitamin C wird von Antikörpern und Kollagen gebildet. Es kann den Stoffwechsel von Phenylalanin, Tyrosin und Folsäure reparieren. Es kann die Verwertung von Eisen und Kohlenhydraten und die Synthese von Fett und Protein fördern. Vitamin C kann die Immunfunktion, die Hydroxylierung und das Serotonin aufrechterhalten, die Integrität der Blutgefässe aufrechterhalten und die Absorption von Nicht-Hämeisen fördern. Zur gleichen Zeit hat Vitamin C auch die Funktionen der Antioxidation, Antifreien Radikalen und Hemmung der Bildung von Tyrosinase.Vitamin C: Vitamin C, also known as ascorbic acid, is a colorless and odorless flaky crystal. Vitamin C is produced by antibodies and collagen. It can repair the metabolism of phenylalanine, tyrosine and folic acid. It can promote the recovery of iron and carbohydrates and the synthesis of fat and protein. Vitamin C can maintain immune function, hydroxylation and serotonin, maintain blood vessel integrity and promote absorption of non-heme iron. At the same time, vitamin C also has the functions of antioxidation, anti-free radicals and inhibiting the formation of tyrosinase.
[0027] Cholin: Cholin ist Bestandteil aller Biofilme und Vorläufer von Acetylcholin in cholinergen Neuronen. Der Erwerb von Cholin im Körper erfolgt durch Nahrung wie Leber, Ei oder endogenes synthetisches Phosphatidylcholin. Zusätzlich zum Erhalt von Cholin aus dem Körper als Teil des makrophasischen Phosphatidylcholins kann der Körper auf andere Weise kein Cholin produzieren. Cholin hat die Funktionen, die Gehirnentwicklung zu fördern und das Gedächtnis zu verbessern, die Informationsübertragung zu gewährleisten, die Apoptose zu regulieren, einen wichtigen Bestandteil des Biofilms zu bilden, den Fettstoffwechsel zu fördern, den Stoffwechsel im Körper zu fördern und das Serumcholesterin zu senken.Choline: Choline is a component of all biofilms and precursors of acetylcholine in cholinergic neurons. Choline is acquired in the body through food such as liver, egg or endogenous synthetic phosphatidylcholine. In addition to receiving choline from the body as part of the macrophasic phosphatidylcholine, the body cannot otherwise produce choline. Choline has the functions of promoting brain development and improving memory, ensuring the transmission of information, regulating apoptosis, forming an important component of biofilm, promoting fat metabolism, promoting metabolism in the body and lowering serum cholesterol.
[0028] Gynostemma pentaphyllum: Die Hauptwirkstoffe von Gynostemma pentaphyllum sind Gynostemma pentaphyllum, Gynostemma (Polysaccharid), wasserlösliche Aminosäuren, Flavonoide, Multivitamine, Spurenelemente, Mineralien und so weiter. Die Basis des Arzneimittels von Gynostemma pentaphyllum ist das ganze Gras der Kürbisgewächse Gynostemma pentaphyllum. Es hat eine milde Natur und einen leicht bitteren Geschmack. Es hat entzündungshemmende und entgiftende Wirkung und beruhigt den Husten. Die Hauptkomponenten von Gynostemma pentaphyllum können körperliche Schwäche, Leukopenie, Hyperlipidämie, Virushepatitis, chronische Gastroenteritis, chronische Bronchitis usw. behandeln und werden gegenwärtig als Gesundheitspflegeprodukte verwendet.Gynostemma pentaphyllum: The main active ingredients of Gynostemma pentaphyllum are Gynostemma pentaphyllum, Gynostemma (polysaccharide), water-soluble amino acids, flavonoids, multivitamins, trace elements, minerals and so on. The basis of the drug from Gynostemma pentaphyllum is the whole grass of the pumpkin family Gynostemma pentaphyllum. It has a mild nature and a slightly bitter taste. It has anti-inflammatory and detoxifying effects and soothes the cough. The main components of Gynostemma pentaphyllum can treat physical weakness, leukopenia, hyperlipidemia, viral hepatitis, chronic gastroenteritis, chronic bronchitis, etc., and are currently used as health care products.
[0029] Maispeptid: Maispeptid ist ein Protein, das aus Mais extrahiert wird. Es ist ein kleines Nahrungsmittelpeptidmaterial, das durch gerichtete Verdauung und spezifische kleine Peptidseparationstechnologie erhalten wird. Es ist ein natürliches Lebensmittelprotein, sicher und zuverlässig, und hat keine toxischen Nebenwirkungen. Maispeptid enthält viele Nährstoffe und verschiedene Aminosäuren, die für den menschlichen Körper notwendig sind, um Aminosäuren und Peptide für die Ernährung bereitzustellen. Maispeptid hat die Funktionen, Blutdruck, Kater-Symptome und Müdigkeit zu senken, die Leber zu schützen und die Immunität des Körpers zu verbessern und wird leicht vom menschlichen Körper absorbiert.Corn Peptide: Corn peptide is a protein extracted from corn. It is a small food peptide material that is obtained through directed digestion and specific small peptide separation technology. It is a natural food protein, safe and reliable, and has no toxic side effects. Corn peptide contains many nutrients and various amino acids that are necessary for the human body to provide amino acids and peptides for nutrition. Corn peptide has the functions of lowering blood pressure, hangover symptoms and fatigue, protecting the liver and improving the immunity of the body and is easily absorbed by the human body.
CH 714 997 B1 [0030] Maisprotein: Maisprotein enthält viele Proteine und hat einen besonderen Geschmack und eine besondere Farbe. Maisproteinmehl wird als Rohstoff zur Extraktion von Zeaxanthin und Maisbrei verwendet, der zu einem funktionellen Lebensmittel entwickelt wird, wobei der Mehrwert erheblich verbessert wird.CH 714 997 B1 Corn Protein: Corn protein contains many proteins and has a special taste and color. Corn protein flour is used as a raw material for the extraction of zeaxanthin and corn porridge, which is being developed into a functional food, whereby the added value is significantly improved.
[0031] Mate-Tee-Pulver: Mate-Tee-Pulver enthält eine Vielzahl von essentiellen Vitaminen und Mineralien, einschliesslich Vitaminen, Eisen, Kalzium, Ballaststoffen etc., kann einen leichten Mangel an Nährstoffen des Körpers beheben, bei Defäkation helfen, und ist ein rein natürliches Getränk, welches einen Gewichtsverlust bewirkt. Mate-Tee hat auch die Funktion, die Nerven zu erfrischen, den Darm zu erfrischen und das Blutfett und den Blutdruck zu senken.Mate Tea Powder: Mate Tea Powder contains a variety of essential vitamins and minerals, including vitamins, iron, calcium, fiber, etc., can remedy a slight lack of nutrients in the body, help with defecation, and is a purely natural drink that causes weight loss. Mate tea also has the function of refreshing the nerves, refreshing the intestines and lowering blood fat and blood pressure.
[0032] Hefe: Hefe ist ein winziger einzelliger Mikroorganismus, der für das blosse Auge unsichtbar ist und ein natürlicher Starter ist. Weil es viele physiologisch aktive Substanzen wie Proteine, Vitamine und Enzyme enthält, wird es zu Hefetabletten zur Behandlung von Dyspepsie, die durch eine unangemessene Diät verursacht wird, hergestellt. Eine Person mit einer schwachen Konstitution kann eine gewisse Rolle bei der Anpassung der Stoffwechselfunktion spielen. Im Hefekulturprozess können z.B. einige spezielle Elemente hinzugefügt werden, um Hefe zu bilden, die Spurenelemente wie Selen und Chrom enthält. Dies hat bestimmte heilende Wirkung auf einige Krankheiten. Zum Beispiel wird selenhaltige Hefe verwendet, um die Keshan-Krankheit und die Kaschin-Beck-Krankheit zu behandeln, und hat bestimmte Wirkungen der Verhinderung der Zellalterung; chromhaltige Hefe kann zur Behandlung von Diabetes verwendet werden.Yeast: Yeast is a tiny unicellular microorganism that is invisible to the naked eye and is a natural starter. Because it contains many physiologically active substances such as proteins, vitamins and enzymes, it is made into yeast tablets for the treatment of dyspepsia caused by an inappropriate diet. A person with a weak constitution can play a certain role in adapting the metabolic function. In the yeast culture process e.g. some special elements are added to form yeast that contains trace elements like selenium and chromium. This has certain healing effects on some diseases. For example, selenium-containing yeast is used to treat Keshan disease and Kashin-Beck disease and has certain effects in preventing cell aging; Chromium-containing yeast can be used to treat diabetes.
[0033] Ein festes Präparat für die Zubereitung eines funktionellen Getränks, umfassend die folgenden Gewichtskomponenten: 14 bis 16 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 14 bis 16 Mengen Sojapeptid; 14 bis 16 Mengen Kollagen-Tripeptid; 14 bis 16 Mengen Bittermelone-Extrakt; 14 bis 16 Mengen Yak-Knochenmark-Extrakt; 9 bis 12 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.2 bis 0.8 Mengen Seegurkenextrakt; 0.2 bis 0.8 Mengen Coenzym Q10; 0.2 bis 0.3 Mengen Selenoprotein; 0.05 bis 0.1 Mengen Lutein; 0.2 bis 0.3 Mengen Caseinphosphopeptid; 0.03 bis 0.1 Mengen Vitamin B1; 0.03 bis 0.1 Mengen Cholin; 0.05 bis 0.15 Mengen Vitamin C; 4 bis 6 Mengen Gynostemma-pentaphyllum-Extrakt; 4 bis 6 Mengen von einem aus Mais extrahierten Peptid; 0.05 bis 2 Mengen von einem aus Mais extrahierten Protein; 0.05 bis 2 Mengen Mate-Tee-Pulver; 0.02 bis 0.06 Mengen Hefe.A solid preparation for the preparation of a functional drink comprising the following weight components: 14 to 16 amounts of collagen extracted from the skin of deep-sea cod; 14 to 16 amounts of soy peptide; 14 to 16 amounts of collagen tripeptide; 14 to 16 quantities of bitter melon extract; 14 to 16 amounts of yak bone marrow extract; 9 to 12 amounts of oil extracted from Rana Sylvatica; 0.2 to 0.8 quantities of sea cucumber extract; 0.2 to 0.8 amounts of coenzyme Q10; 0.2 to 0.3 amounts of selenoprotein; 0.05 to 0.1 amounts of lutein; 0.2 to 0.3 amounts of casein phosphopeptide; 0.03 to 0.1 amounts of vitamin B1; 0.03 to 0.1 amounts of choline; 0.05 to 0.15 amounts of vitamin C; 4 to 6 amounts of Gynostemma pentaphyllum extract; 4 to 6 amounts of a peptide extracted from corn; 0.05 to 2 amounts of a protein extracted from corn; 0.05 to 2 quantities of mate tea powder; 0.02 to 0.06 quantities of yeast.
[0034] Die Zubereitung des funktionellen Getränks mit dem erfindungsgemässen Präparat erfordert eine gründliche Auflösung mit warmem Wasser, das vor dem Trinken 60 °C übersteigt.The preparation of the functional drink with the preparation according to the invention requires thorough dissolution with warm water that exceeds 60 ° C before drinking.
Beispiel 1:Example 1:
[0035] Festes Präparat für die Zubereitung eines funktionellen Getränks umfassend die folgenden Gewichtskomponenten: 15 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 15 Mengen Sojapeptid; 15 Mengen KollagenTripeptid; 15 Mengen Bittermelone-Extrakt; 15 Mengen Yak-Knochenmark-Extrakt; 10 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.5 Mengen Seegurkenextrakt; 0.5 Mengen Coenzym 010; 0.25 Mengen Selenoprotein; 0.05 Mengen Lutein; 0.25 Mengen Caseinphosphopeptid; 0.05 Mengen Vitamin B1; 0.05 Mengen Cholin; 0.1 Mengen Vitamin C; 5 Mengen Gynostemma-pentaphyllum-Extrakt; 5 Mengen von einem aus Mais extrahierten Peptid; 1 Menge von einem aus Mais extrahierten Protein; 1 Menge Mate-Tee-Pulver; 0.05 Mengen Hefe.Solid preparation for the preparation of a functional drink comprising the following weight components: 15 amounts of collagen extracted from the skin of deep-sea cod; 15 quantities of soy peptide; 15 amounts of collagen tripeptide; 15 quantities of bitter melon extract; 15 quantities of yak bone marrow extract; 10 quantities of oil extracted from Rana Sylvatica; 0.5 quantities of sea cucumber extract; 0.5 quantities of coenzyme 010; 0.25 quantities of selenoprotein; 0.05 amounts of lutein; 0.25 quantities of casein phosphopeptide; 0.05 amounts of vitamin B1; 0.05 amounts of choline; 0.1 amounts of vitamin C; 5 quantities of Gynostemma pentaphyllum extract; 5 amounts of a peptide extracted from corn; 1 amount of a protein extracted from corn; 1 amount of mate tea powder; 0.05 quantities of yeast.
[0036] Ein Herstellungsverfahren für das feste Präparat für die Zubereitung eines funktionellen Getränks, gekennzeichnet durch die folgenden Schritte:A manufacturing process for the solid preparation for the preparation of a functional drink, characterized by the following steps:
[0037] (1) Die Rohmaterialien werden gemäss dem obigen Gewichtsverhältnis gewogen;(1) The raw materials are weighed according to the above weight ratio;
[0038] (2) aus der Haut von Tiefsee-Kabeljau extrahiertes Kollagen, Sojapeptid, Bittermelone-Extrakt, Yak-KnochenmarkExtrakt, aus Rana Sylvatica extrahiertes Öl, Seegurkenextrakt, Gynostemma-pentaphyllum-Extrakt, ein aus Mais extrahiertes Peptid und Mate-Tee-Pulver werden zusammengemischt und einheitlich gerührt, um ein Rohmaterialpulver zu bilden;(2) Collagen extracted from the skin of deep-sea cod, soy peptide, bitter melon extract, yak bone marrow extract, oil extracted from Rana Sylvatica, sea cucumber extract, gynostemma pentaphyllum extract, a peptide extracted from maize and mate tea. Powders are mixed together and stirred uniformly to form a raw material powder;
[0039] (3) Coenzym 010, Selenoprotein, Lutein, Caseinphosphopeptid, Vitamin B1, Cholin, Vitamin C, ein aus Mais extrahiertes Protein und Hefe werden dem Rohmaterialpulver zugebracht, gleichmässig gemischt und dann getrocknet.(3) Coenzyme 010, selenoprotein, lutein, casein phosphopeptide, vitamin B1, choline, vitamin C, a protein extracted from corn and yeast are added to the raw material powder, mixed uniformly and then dried.
Beispiel 2:Example 2:
[0040] Festes Präparat für die Zubereitung eines funktionellen Getränks umfassend die folgenden Gewichtskomponenten: 15 Mengen von aus der Haut von Tiefsee-Kabeljau extrahiertem Kollagen; 15 Mengen Sojapeptid; 15 Mengen KollagenTripeptid; 15 Mengen Bittermelone-Extrakt; 15 Mengen Yak-Knochenmark-Extrakt; 10 Mengen von aus Rana Sylvatica extrahiertem Öl; 0.5 Mengen Seegurkenextrakt; 0.5 Mengen Coenzym 010; 0.25 Mengen Selenoprotein; 0.05 Mengen Lutein; 0.2 Mengen Caseinphosphopeptid; 0.05 Mengen Vitamin B1; 0.05 Mengen Cholin; 0.15 Mengen Vitamin C; 5 Mengen Gynostemma-pentaphyllum-Extrakt; 5 Mengen von einem aus Mais extrahierten Peptid; 1 Menge von einem aus Mais extrahierten Protein; 1 Menge Mate-Tee-Pulver; 0.05 Mengen Hefe.Solid preparation for the preparation of a functional drink comprising the following weight components: 15 amounts of collagen extracted from the skin of deep-sea cod; 15 quantities of soy peptide; 15 amounts of collagen tripeptide; 15 quantities of bitter melon extract; 15 quantities of yak bone marrow extract; 10 quantities of oil extracted from Rana Sylvatica; 0.5 quantities of sea cucumber extract; 0.5 quantities of coenzyme 010; 0.25 quantities of selenoprotein; 0.05 amounts of lutein; 0.2 amounts of casein phosphopeptide; 0.05 amounts of vitamin B1; 0.05 amounts of choline; 0.15 quantities of vitamin C; 5 quantities of Gynostemma pentaphyllum extract; 5 amounts of a peptide extracted from corn; 1 amount of a protein extracted from corn; 1 amount of mate tea powder; 0.05 quantities of yeast.
[0041] Ein Herstellungsverfahren für das feste Präparat für die Zubereitung eines funktionellen Getränks, gekennzeichnet durch die folgenden Schritte:A manufacturing method for the solid preparation for the preparation of a functional drink, characterized by the following steps:
[0042] (1) Die Rohmaterialien werden gemäss dem obigen Gewichtsverhältnis gewogen;(1) The raw materials are weighed according to the above weight ratio;
CH 714 997 B1 [0043] (2) aus der Haut von Tiefsee-Kabeljau extrahiertes Kollagen, Sojapeptid, Bittermelone-Extrakt, Yak-KnochenmarkExtrakt, aus Rana Sylvatica extrahiertes Öl, Seegurkenextrakt, Gynostemma-pentaphyllum-Extrakt, ein aus Mais extrahiertes Peptid und Mate-Tee-Pulver werden zusammengemischt und einheitlich gerührt, um ein Rohmaterialpulver zu bilden; [0044] (3) Coenzym Q10, Selenoprotein, Lutein, Caseinphosphopeptid, Vitamin B1, Cholin, Vitamin C, ein aus Mais extrahiertes Protein und Hefe werden dem Rohmaterialpulver zugebracht, gleichmässig gemischt und dann getrocknet.CH 714 997 B1 (2) Collagen extracted from the skin of deep-sea cod, soy peptide, bitter melon extract, yak bone marrow extract, oil extracted from Rana Sylvatica, sea cucumber extract, gynostemma pentaphyllum extract, a peptide extracted from corn and Mate tea powders are mixed together and stirred uniformly to form a raw material powder; (3) Coenzyme Q10, selenoprotein, lutein, casein phosphopeptide, vitamin B1, choline, vitamin C, a protein extracted from corn and yeast are added to the raw material powder, mixed uniformly and then dried.
[0045] Das erfindungsgemässe Präparat ist vernünftig, übt vollständig die Vorteile jedes Rohmaterials aus, hat die Wirkungen der Erleichterung der Ermüdung, der Verbesserung der physikalischen Stärke, der Aufrechterhaltung der Energie und dergleichen, und hat beim Langzeittrinken eine umfassende körperregulierende Wirkung auf das menschliche Herz, Knochen, Haut, Magen, Leber und dergleichen.The preparation of the present invention is reasonable, fully exerts the advantages of each raw material, has the effects of relieving fatigue, improving physical strength, maintaining energy and the like, and has a comprehensive body-regulating effect on the human heart in long-term drinking , Bones, skin, stomach, liver and the like.
[0046] Das erfindungsgemässe Präparat hat auch die vorteilhaften Wirkungen der Regulierung von Blutzucker, Blutdruck, Blutlipidbalance, Schutz von Zellen, Schutz von inneren Organen, Förderung der Nährstoffabsorption und Eliminierung von toxischen Substanzen im Darm, Verbesserung der Immunität und der Antikrebswirkung.The preparation according to the invention also has the advantageous effects of regulating blood sugar, blood pressure, blood lipid balance, protecting cells, protecting internal organs, promoting nutrient absorption and eliminating toxic substances in the intestine, improving immunity and the anti-cancer effect.
[0047] Die obige Beschreibung ist nur eine bevorzugte Ausführungsform der vorliegenden Erfindung und soll die Erfindung nicht beschränken. Irgendwelche Modifikationen, äquivalente Substitutionen und Verbesserungen, die innerhalb des Grundgedankens und der Prinzipien der vorliegenden Erfindung gemacht werden, sollen in den Umfang der vorliegenden Erfindung eingeschlossen sein.The above description is only a preferred embodiment of the present invention and is not intended to limit the invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention are intended to be included within the scope of the present invention.
Angaben über die Quelle genetischer Ressourcen und traditionellen Wissens gemäss Art. 49a PatG [0048] Die Erfindung beruht nicht direkt auf die folgenden Ressourcen, es wurden ausschliesslich Extrakte verwendet, die im Handel erhalten worden sind: Tiefsee-Kabeljau-Kollagen, Sojapeptid, Kollagen-Tripeptid, Bittermelone-Extrakt, YakKnochenmark-Extrakt, Froschöl (aus Rana Sylvatica extrahiertem Öl), Seegurkenextrakt, Coenzym Q10, Selenoprotein, Lutein, Caseinphosphopeptid, Vitamin B1, Cholin, Vitamin C, Gynostemma-pentaphyllum-Extrakt, Maispeptid (einem aus Mais extrahierten Peptid), Maisprotein (einem aus Mais extrahierten Protein), Hefe.Information about the source of genetic resources and traditional knowledge according to Art. 49a PatG [0048] The invention is not based directly on the following resources, only extracts that were obtained commercially were used: deep-sea cod collagen, soy peptide, collagen Tripeptide, bitter melon extract, yak bone marrow extract, frog oil (oil extracted from Rana Sylvatica), sea cucumber extract, coenzyme Q10, selenoprotein, lutein, casein phosphopeptide, vitamin B1, choline, vitamin C, gynostemma pentaphyllum extract, maize peptide (one extracted from Peptide), corn protein (a protein extracted from corn), yeast.
[0049] Das Mate-Tee-Pulver besteht aus trockenen Blättern des Mate-Strauchs Hex paraguariensis und wurde aus Südamerika bezogen (Paraguay, Brasilien, Argentinien und/oder Ecuador).The mate tea powder consists of dry leaves of the mate shrub Hex paraguariensis and was sourced from South America (Paraguay, Brazil, Argentina and / or Ecuador).
[0050] Die Erfindung ist ein Präparat basierend auf der chinesischen traditionellen Medizin.The invention is a preparation based on Chinese traditional medicine.
[0051] Angaben über die Quelle genetischer Ressourcen und traditionellen Wissens laut Art. 49a PatG:Information on the source of genetic resources and traditional knowledge according to Art. 49a PatG:
Genetische Ressource(n): Quellen der genetischen Ressource(n):Genetic resource (s): Sources of the genetic resource (s):
Mate-Tee-Pulver Paraguay, Brasilien, Argentinien und/oder EcuadorMate tea powder Paraguay, Brazil, Argentina and / or Ecuador
Traditionelles Wissen Traditionelle chinesische MedizinTraditional knowledge Traditional Chinese medicine
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810913958.8A CN108967800A (en) | 2018-08-13 | 2018-08-13 | A kind of functional solid beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CH714997B1 true CH714997B1 (en) | 2019-11-15 |
Family
ID=64552980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH10052018A CH714997B1 (en) | 2018-08-13 | 2018-08-17 | Solid preparation for the preparation of a functional beverage and process for its preparation. |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108967800A (en) |
CH (1) | CH714997B1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110959688A (en) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | Protein fiber milk shake powder and preparation method thereof |
CN111374243A (en) * | 2020-04-27 | 2020-07-07 | 百生康(北京)健康产业科技有限公司 | Compound children nutrient beverage and preparation method thereof |
CN112715957A (en) * | 2020-12-04 | 2021-04-30 | 广州音波美健康生物科技有限公司 | Biological small molecular peptide composition for dispelling effects of alcohol and protecting liver and preparation method thereof |
CN112956702A (en) * | 2021-03-25 | 2021-06-15 | 江西邦泰绿色生物合成生态产业园发展有限公司 | Compound preparation for increasing bone mineral density |
CN115363203A (en) * | 2022-08-23 | 2022-11-22 | 广东官栈营养健康科技有限公司 | Instant flower gum with anti-aging effect and preparation method thereof |
CN115644326A (en) * | 2022-09-26 | 2023-01-31 | 海南华研胶原科技股份有限公司 | Functional beverage containing collagen tripeptide and preparation method thereof |
CN115944088A (en) * | 2022-12-20 | 2023-04-11 | 江西盖比欧科技有限公司 | Protein powder for body-building meal replacement and preparation method thereof |
CN116035175A (en) * | 2022-10-21 | 2023-05-02 | 中国人民解放军陆军勤务学院 | Novel plateau animal and plant composite functional rod and preparation method thereof |
CN117925759A (en) * | 2024-01-23 | 2024-04-26 | 通化康元生物科技有限公司 | Wood frog polypeptide preparation and application thereof in food and cosmetics |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110338344A (en) * | 2019-08-02 | 2019-10-18 | 王中华 | A kind of compound nutritional bone peptide butterfly pattern face and preparation method thereof |
CN110604295A (en) * | 2019-10-11 | 2019-12-24 | 王中华 | Composite bone peptide and preparation method thereof |
KR102236944B1 (en) * | 2020-04-29 | 2021-04-06 | (주)네오크레마 | Functional food composition and cosmetic composition comprising galacto-oligosaccharide, or galacto-oligosaccharide and collagen tripeptides for improving immune function and skin condition |
CN112493385A (en) * | 2020-11-27 | 2021-03-16 | 中国科学院过程工程研究所 | Compound protein peptide beverage with whitening function |
CN113455602A (en) * | 2021-05-31 | 2021-10-01 | 覃宇华 | Plant enzyme peptide beverage and preparation method thereof |
CN113694179B (en) * | 2021-08-20 | 2024-05-10 | 安徽国肽生物科技有限公司 | Preparation method and application of ternary polypeptide nano-particles based on yak bone peptide |
CN114343187A (en) * | 2021-12-27 | 2022-04-15 | 北京康比特体育科技股份有限公司 | Health beverage containing collagen tripeptide and preparation method thereof |
CN114747704A (en) * | 2022-02-28 | 2022-07-15 | 澳美制药(苏州)有限公司 | Eye-protecting, beautifying and face-nourishing beverage and preparation method thereof |
CN114887029B (en) * | 2022-05-20 | 2023-03-21 | 广东海洋大学 | Pharmaceutical composition, preparation method and application thereof |
CN115736258A (en) * | 2022-12-29 | 2023-03-07 | 大连非得生物产业有限公司 | Yak bone renaturation oligopeptide powder and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100438781C (en) * | 2004-12-10 | 2008-12-03 | 何建强 | Health-care beverage and its prepn. method |
CN105476030A (en) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | Multi-functional composite oligopeptide nutrition powder |
CN106333370A (en) * | 2016-08-19 | 2017-01-18 | 江西中天医药生物有限公司 | Health food prepared from selenium-enriched yeast and calcium carbonate as main raw materials and used for supplementing selenium and calcium for human body |
CN106359604B (en) * | 2016-08-24 | 2019-06-18 | 北京三元食品股份有限公司 | A kind of infant formula and preparation method thereof promoting intestinal health |
CN108142952A (en) * | 2017-12-25 | 2018-06-12 | 安徽生物肽产业研究院有限公司 | A kind of complex peptides powder for improving fatigue, improving immunization |
CN108113007A (en) * | 2018-01-10 | 2018-06-05 | 安徽中森生物技术有限公司 | A kind of composition containing soybean protein and yak marrow and preparation method thereof |
CN108308488A (en) * | 2018-04-12 | 2018-07-24 | 北京昱健健康管理有限公司 | Give birth to peptide solid beverage in the sources D- |
-
2018
- 2018-08-13 CN CN201810913958.8A patent/CN108967800A/en active Pending
- 2018-08-17 CH CH10052018A patent/CH714997B1/en not_active IP Right Cessation
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110959688A (en) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | Protein fiber milk shake powder and preparation method thereof |
CN111374243A (en) * | 2020-04-27 | 2020-07-07 | 百生康(北京)健康产业科技有限公司 | Compound children nutrient beverage and preparation method thereof |
CN112715957A (en) * | 2020-12-04 | 2021-04-30 | 广州音波美健康生物科技有限公司 | Biological small molecular peptide composition for dispelling effects of alcohol and protecting liver and preparation method thereof |
CN112956702A (en) * | 2021-03-25 | 2021-06-15 | 江西邦泰绿色生物合成生态产业园发展有限公司 | Compound preparation for increasing bone mineral density |
CN115363203A (en) * | 2022-08-23 | 2022-11-22 | 广东官栈营养健康科技有限公司 | Instant flower gum with anti-aging effect and preparation method thereof |
CN115644326A (en) * | 2022-09-26 | 2023-01-31 | 海南华研胶原科技股份有限公司 | Functional beverage containing collagen tripeptide and preparation method thereof |
CN116035175A (en) * | 2022-10-21 | 2023-05-02 | 中国人民解放军陆军勤务学院 | Novel plateau animal and plant composite functional rod and preparation method thereof |
CN115944088A (en) * | 2022-12-20 | 2023-04-11 | 江西盖比欧科技有限公司 | Protein powder for body-building meal replacement and preparation method thereof |
CN117925759A (en) * | 2024-01-23 | 2024-04-26 | 通化康元生物科技有限公司 | Wood frog polypeptide preparation and application thereof in food and cosmetics |
Also Published As
Publication number | Publication date |
---|---|
CN108967800A (en) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH714997B1 (en) | Solid preparation for the preparation of a functional beverage and process for its preparation. | |
CN109730232A (en) | A kind of face beautifying and nourishing drink and preparation method thereof | |
RU2315487C1 (en) | Biologically active product from brown algae, biologically active food supplement, soft drink, perfume and cosmetic agent | |
KR101541516B1 (en) | Mathod Manufacturing lON Mineral Using Silk worm, Muberry leaf, and Muberry twig And Health Drink Manufactured by this | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
CN103976203B (en) | Jelly of a kind of beautifying face and moistering lotion and preparation method thereof | |
CN107242527B (en) | Preparation method of edible rose sauce suitable for middle-aged and elderly people | |
CN111374297A (en) | Compound salt and preparation method thereof | |
CN102077939A (en) | Marine special dietary food special for fat people | |
CN108813246A (en) | A kind of easy anti-ageing composition of collagen peptide and its preparation process for absorbing Anti-lost | |
CN102077937A (en) | Special dietary seafood special for young and middle-aged women | |
CN102077944B (en) | Marine special dietary food special for prostate patient | |
Bayramov et al. | APPLICATION OF PERSIMMON SYRUP TO INCREASE THE BIOLOGICAL VALUE AND ORGANOLEPTIC INDICATORS OF BREAD. | |
CN103976202B (en) | A kind of edible collagen protein jelly and preparation method thereof | |
CN105230890A (en) | Health care horseradish tree tea | |
CN104757689A (en) | Solid beverage with pine pollen, taurine and vitamins, and preparation method of the solid beverage | |
KR101981564B1 (en) | Functional Kimchi Using Granulated and Its Manufacturing Method | |
CN104431125A (en) | Sea-buckthorn honey tea and preparation method thereof | |
CN103976211B (en) | Jelly of a kind of fat-reducing and preparation method thereof | |
CN110710625A (en) | Tremella compound suspension beverage and preparation method thereof | |
CN111939115A (en) | Natural plant essence repairing mask and preparation method thereof | |
CN102077943A (en) | Seafood for special dietary uses for hypomnesia patients | |
CN101336719B (en) | Nutrient powder capable of expelling toxin and preventing cancer | |
KR102480311B1 (en) | The manufacturing method of making healthcare food composition for costitutional group | |
CN106360207A (en) | Method for producing chitosan oligosaccharide, maca and ginseng functional beverage, and functional beverage produced through method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCAR | Change of the address of the representative |
Free format text: NEW ADDRESS: BERGLIHOEH 3, 8725 ERNETSCHWIL (CH) |
|
PL | Patent ceased | ||
PK | Correction |
Free format text: BERICHTIGUNG |